Featured Articles

  1. Corporate Spin-Offs And NewCos: Unlocking Value in Biopharma Innovation 12/2/2025

    Corporate spin-offs and NewCos can attract focused investment and accelerate innovation amid rising R&D costs, writes Joseph Pategou.

  2. Galien Forum: CEOs Talk FDA, China, Funding Sources 11/25/2025

    Part two of a two-part series covering FDA Commissioner Makary’s comments at the Galien Forum on October 30, plus coverage of a CEO roundtable on FDA, China, and funding.

  3. From Funding Gaps to AI Frontiers: Insights from the Boston Globe Summit 2025 11/20/2025

    Insights from the Boston Globe Summit 2025 exploring biotech funding challenges, AI-driven drug discovery, and genome editing breakthroughs shaping the future of research and care.

  4. Winning Strategies For Life Sciences In A Converging Policy Landscape 11/18/2025

    The simultaneous impacts of global trade shifts, U.S. tax reforms, and changing drug pricing policies have prompted life sciences companies to reevaluate their strategies, write experts at KPMG.

  5. Biotech Financing: Why Strong IP Is The Currency of Collaboration 11/11/2025

    Strong IP keeps collaboration alive, allowing companies to attract capital, strike partnerships, and bring innovations to patients, according to legal experts at Ice Miller.

  6. The Future Of Biologistics 11/7/2025

    Tom Wells at 4C Associates, explores the future of 'biologistics,' or how the packaging, storage, and logistics for biologics might develop over the next two decades, with supply chain implications.

  7. Someone Else Can Schedule The Meeting 11/5/2025

    Leadership means knowing when to jump in and when to let someone else worry about the details, writes Hope Mueller, SVP of Corporate Development and Strategy at Currax Pharmaceuticals.

  8. M&A In GLP-1 Technology: Practical Recommendations And Best Practices 11/4/2025

    With explosive demand, expanding indications, and rapid innovation, the GLP-1 revolution is reshaping dealmaking. Here's a practical guide for companies negotiating M&A in this arena.

  9. How The U.S. Can Beat China In Biotech 11/3/2025

    Lumen Bioscience's Brian Finrow breaks down China's biotech playbook and explores ways the U.S. can adapt it for its own continued success.

  10. Makary Talks Faster Drug Reviews, 'Continuous Trials,' DTC Ads 10/31/2025

    Part one of a two-part series on FDA Commissioner Martin Makary, M.D.'s comments at the Gailen Forum in New York City on October 30, 2025.